Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments-a systematic review.

Autor: Olivares-Hernández A; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., González Del Portillo E; Department of Radiotherapy, University Hospital La Paz, Madrid, Spain., Tamayo-Velasco Á; Department of Hematology, University Clínico de Valladolid, Valladolid, Spain., Figuero-Pérez L; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Zhilina-Zhilina S; University Hospital Fuenlabrada, Madrid, Spain., Fonseca-Sánchez E; Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca, Salamanca, Spain., Miramontes-González JP; Department of Internal Medicine, University Hospital Rio Hortega, Valladolid, Spain.; Faculty of Medicine, University of Valladolid, Valladolid, Spain.

Publikováno v: Annals of translational medicine [Ann Transl Med] 2023 Aug 30; Vol. 11 (10), pp. 354. Date of Electronic Publication: 2023 May 23.